'Who wants to make money?' Court documents outline wild fraud scheme targeting Gilead HIV meds

Gilead Sciences has closed the books on its multimillion-dollar HIV PrEP fraud case. After a court in Miami last month ordered bank account freezes for the “kingpin” defendants in the scheme, Gilead has settled with them for an undisclosed amount.